Pharmacosmos

📍 Holbaek, Denmark🗓 Founded 1965👥 381 employees💰 Last funded Jun 2024
Pharmaceutical Manufacturing🌐 pharmacosmos.com
Website LinkedIn
Pharmacosmos is considered a world leading authority in treatment of iron deficiency anaemia. Headquartered in Denmark, Pharmacosmos is a family-owned, international healthcare company with more than 50 years of innovation and leadership in iron- and carbohydrate-based treatments and solutions for human and animal use. A research-based company, its ongoing R&D programme focuses on improving the lives of patients with iron deficiency with or without anaemia. More than 1 billion people live with iron deficiency anaemia and it is the leading cause of death for an estimated 180,000 people every year. This makes it one of the largest global health challenges of our time. Pharmacosmos has affiliates in the US, China, UK, Ireland, Germany, Sweden and Norway and its products are marketed in more than 80 countries across the world. Its manufacturing facilities are approved, among others, by the Danish Medicines Agency and the US FDA.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
1965
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Denmark
2
Frequently asked questions
Who invested in Pharmacosmos?
Pharmacosmos has 2 investors on record on gritt.io.
When did Pharmacosmos last raise funding?
The most recent investment in Pharmacosmos recorded on gritt.io was in June 2024.
When was Pharmacosmos founded?
Pharmacosmos was founded in 1965.
What industry is Pharmacosmos in?
Pharmacosmos operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Pharmacosmos based?
Pharmacosmos is headquartered in Holbaek, Denmark.